Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


08.05.2017

1 Ann Intern Med
1 BMC Pediatr
4 J Gen Virol
1 J Immunol
5 J Infect Dis
1 J Virol
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 PLoS Med
6 PLoS One
3 Science
22 Vaccine
4 Virology
1 Virus Res
1 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. ANDERSON KB, Thomas SJ, Endy TP
    The Emergence of Zika Virus: A Narrative Review.
    Ann Intern Med. 2016 May 3. doi: 10.7326/M16-0617.
    PubMed     Text format     Abstract available


    BMC Pediatr

  2. DIAWARA I, Zerouali K, Elmdaghri N, Abid A, et al
    A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
    BMC Pediatr. 2017;17:114.
    PubMed     Text format     Abstract available


    J Gen Virol

  3. YAMANAKA A, Moi ML, Takasaki T, Kurane I, et al
    Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients.
    J Gen Virol. 2017;98:166-172.
    PubMed     Text format     Abstract available

  4. GARCIA M, Spatz SJ, Cheng Y, Riblet SM, et al
    Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    J Gen Virol. 2016;97:2352-62.
    PubMed     Text format     Abstract available

  5. KUAH LF, Tang LH, Sutton T, Lim JH, et al
    Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000683.
    PubMed     Text format     Abstract available

  6. KUZMENKO YV, Starodubova ES, Shevtsova AS, Chernokhaeva LL, et al
    Intracellular degradation and localization of NS1 of tick-borne encephalitis virus affect its protective properties.
    J Gen Virol. 2017;98:50-55.
    PubMed     Text format     Abstract available


    J Immunol

  7. TIAN T, Jin MQ, Dubin K, King SL, et al
    IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.
    J Immunol. 2017 May 3. pii: 1500106. doi: 10.4049/jimmunol.1500106.
    PubMed     Text format     Abstract available


    J Infect Dis

  8. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017;215:928-932.
    PubMed     Text format     Abstract available

  9. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
    J Infect Dis. 2017;215:844-846.
    PubMed     Text format    

  10. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Text format     Abstract available

  11. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed     Text format    

  12. LINDESMITH LC, Mallory ML, Jones TA, Richardson C, et al
    Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
    J Infect Dis. 2017;215:984-991.
    PubMed     Text format     Abstract available


    J Virol

  13. CASTRO I, Giret TM, Magnani DM, Maxwell HS, et al
    Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.
    J Virol. 2016;90:5280-91.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  14. BRICKLEY EB, Wright PF
    Maximising the impact of inactivated polio vaccines.
    Lancet Infect Dis. 2017 Apr 25. pii: S1473-3099(17)30236.
    PubMed     Text format    

  15. RIVERA L, Pedersen RS, Pena L, Olsen KJ, et al
    Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, ra
    Lancet Infect Dis. 2017 Apr 25. pii: S1473-3099(17)30177.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  16. GERSHMAN MD, Angelo KM, Ritchey J, Greenberg DP, et al
    Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.
    MMWR Morb Mortal Wkly Rep. 2017;66:457-459.
    PubMed     Text format     Abstract available


    PLoS Med

  17. LI S, Ma C, Hao L, Su Q, et al
    Demographic transition and the dynamics of measles in six provinces in China: A modeling study.
    PLoS Med. 2017;14:e1002255.
    PubMed     Text format     Abstract available


    PLoS One

  18. DELEA TE, Weycker D, Atwood M, Neame D, et al
    Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
    PLoS One. 2017;12:e0175721.
    PubMed     Text format     Abstract available

  19. JACKWOOD MW, Lee DH
    Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry.
    PLoS One. 2017;12:e0176709.
    PubMed     Text format     Abstract available

  20. WIJNANS L, Dodd CN, Weibel D, Sturkenboom M, et al
    Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    PLoS One. 2017;12:e0175539.
    PubMed     Text format     Abstract available

  21. SIMOES MJ, Bettencourt C, De Paola R, Giuliani M, et al
    Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.
    PLoS One. 2017;12:e0176177.
    PubMed     Text format     Abstract available

  22. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available

  23. PAULO AC, Sa-Leao R
    Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.
    PLoS One. 2017;12:e0176723.
    PubMed     Text format     Abstract available


    Science

  24. WADMAN M
    Vaccines on trial.
    Science. 2017;356:370-373.
    PubMed     Text format    

  25. WESSEL L
    Vaccine myths.
    Science. 2017;356:368-372.
    PubMed     Text format    

  26. WADMAN M, You J
    The vaccine wars.
    Science. 2017;356:364-365.
    PubMed     Text format    


    Vaccine

  27. WICHGERS SCHREUR PJ, van Keulen L, Kant J, Kortekaas J, et al
    Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30498.
    PubMed     Text format     Abstract available

  28. SANDHU SK, Hua W, MaCurdy TE, Franks RL, et al
    Near real-time surveillance for Guillain-Barre syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30439.
    PubMed     Text format     Abstract available

  29. SIL A, Ravi MD, Patnaik BN, Dhingra MS, et al
    Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30315.
    PubMed     Text format     Abstract available

  30. TSABAN G, Ben-Shimol S
    Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30510.
    PubMed     Text format     Abstract available

  31. KOHN M, Schaffner W
    Vaccinating adults with chronic disease: We can do better.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30368.
    PubMed     Text format    

  32. DUNN AG, Surian D, Leask J, Dey A, et al
    Mapping information exposure on social media to explain differences in HPV vaccine coverage in the United States.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30552.
    PubMed     Text format     Abstract available

  33. ZHANG Y, Wu P, Feng L, Yang P, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30436.
    PubMed     Text format     Abstract available

  34. ARRIOLA CS, Vasconez N, Thompson MG, Olsen SJ, et al
    Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30536.
    PubMed     Text format     Abstract available

  35. COHET C, Rosillon D, Willame C, Haguinet F, et al
    Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.
    Vaccine. 2017 Apr 29. pii: S0264-410X(17)30550.
    PubMed     Text format     Abstract available

  36. LEE BY, Wedlock PT, Haidari LA, Elder K, et al
    Economic impact of thermostable vaccines.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30433.
    PubMed     Text format     Abstract available

  37. D'ADDARIO M, Redmond S, Scott P, Egli-Gany D, et al
    Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30448.
    PubMed     Text format     Abstract available

  38. SHANKAR MB, Staples JE, Meltzer MI, Fischer M, et al
    Cost effectiveness of a targeted age-based West Nile virus vaccination program.
    Vaccine. 2017 Apr 26. pii: S0264-410X(16)31149.
    PubMed     Text format     Abstract available

  39. HU D, Bowder D, Wei W, Thompson J, et al
    Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30546.
    PubMed     Text format     Abstract available

  40. DIAZ ORTEGA JL, Castaneda D, Arellano Quintanilla DM, Martinez D, et al
    Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30501.
    PubMed     Text format     Abstract available

  41. LU PJ, O'Halloran A, Kennedy ED, Williams WW, et al
    Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30503.
    PubMed     Text format     Abstract available

  42. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Corrigendum to "Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years" [Vaccine 35 (2017) 1254-1258].
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30553.
    PubMed     Text format    

  43. PERRY J, Towers CV, Weitz B, Wolfe L, et al
    Patient reaction to Tdap vaccination in pregnancy.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30521.
    PubMed     Text format     Abstract available

  44. KAPCZYNSKI DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, et al
    Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30520.
    PubMed     Text format     Abstract available

  45. DOMBKOWSKI KJ, Cowan AE, Reeves SL, Foley MR, et al
    The impacts of email reminder/recall on adolescent influenza vaccination.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30511.
    PubMed     Text format     Abstract available

  46. LOPEZ-MEDINA E, Melgar M, Gaensbauer JT, Bandyopadhyay AS, et al
    Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30519.
    PubMed     Text format     Abstract available

  47. MOBERLEY S, Licciardi PV, Balloch A, Andrews R, et al
    Repeat pneumococcal polysaccharide vaccine in Indigenous Australian adults is associated with decreased immune responsiveness.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30518.
    PubMed     Text format     Abstract available

  48. JIANG P, Cai Y, Chen J, Ye X, et al
    Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
    Vaccine. 2017 Apr 26. pii: S0264-410X(17)30509.
    PubMed     Text format     Abstract available


    Virology

  49. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
    Virology. 2017;507:242-256.
    PubMed     Text format     Abstract available

  50. VELAZQUEZ-SALINAS L, Risatti GR, Holinka LG, O'Donnell V, et al
    Recoding structural glycoprotein E2 in classical swine fever virus (CSFV) produces complete virus attenuation in swine and protects infected animals against disease.
    Virology. 2016;494:178-89.
    PubMed     Text format     Abstract available

  51. LIU R, Wang J, Yang Y, Khan I, et al
    Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice.
    Virology. 2016;497:102-110.
    PubMed     Text format     Abstract available

  52. MATZINGER SR, Opriessnig T, Xiao CT, Catanzaro N, et al
    A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs
    Virology. 2016;498:82-93.
    PubMed     Text format     Abstract available


    Virus Res

  53. MUNOZ-ALIA MA, Casasnovas JM, Celma ML, Carabana J, et al
    Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Virus Res. 2017 Apr 29. pii: S0168-1702(17)30127.
    PubMed     Text format     Abstract available


    Wkly Epidemiol Rec


  54. Measles vaccines: WHO position paper - April 2017.
    Wkly Epidemiol Rec. 2017;92:205-27.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: